Expertise in
27
conditions

Dr. Alexander S. Kuo

Gastroenterology | Hepatology
18133 Ventura Boulevard, Suite 300, 
Tarzana, CA 
Accepting New Patients
Offers Telehealth
20 Years of Experience
Referral may be required
Before you request
Expertise in
27
conditions
18133 Ventura Boulevard, Suite 300, 
Tarzana, CA 

Overview

Alexander Kuo is a Gastroenterologist and a Hepatologist practicing medicine in Tarzana, California. He has been practicing medicine for over 20 years.

Dr. Kuo is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Cirrhosis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 4 clinical trials. Dr. Kuo is currently accepting new patients.

Specialties

Gastroenterology
Hepatology

Licenses

Internal Medicine in CA

Hospital Affiliations

Cedars-Sinai Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Nippon Life
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

18133 Ventura Boulevard, Suite 300, Tarzana, CA 91356

Additional Areas of Focus

Dr. Kuo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Enrollment Status: Completed
Publish Date: December 06, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
Enrollment Status: Terminated
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy
A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

76 Total Publications

Reply: Liver transplantation in AH-ACLF-which condition drives post-transplant outcomes?
Reply: Liver transplantation in AH-ACLF-which condition drives post-transplant outcomes?
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: May 18, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Sergio E Rojter MD A Professional Corp.

1245 Wilshire Blvd Ste 770, 
Los Angeles, CA 
 (17.7 miles away)
310-250-3344
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sergio Rojter is a Hepatologist practicing medicine in Los Angeles, California. Dr. Rojter is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Visceromegaly, Non-Alcoholic Fatty Liver Disease, Hepatitis, and Enlarged Liver.

Expertise in
23
conditions
Dr. Norah A. Terrault
Gastroenterology
Expertise in
23
conditions
Dr. Norah A. Terrault
Gastroenterology
Referral may be required

Los Angeles-Gi Liver Clinic

1510 San Pablo St Ste 200, 
Los Angeles, CA 
 (20.5 miles away)
323-442-8894
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Norah Terrault is a Gastroenterologist practicing medicine in Los Angeles, California. Dr. Terrault is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

UCLA Healt Colorectal Surgery

200 UCLA Medical Plz Ste 214, 
Los Angeles, CA 
 (8.3 miles away)
310-825-6078
Languages Spoken:
English
See accepted insurances

Mohamed El Kabany is a Hepatologist practicing medicine in Los Angeles, California. Dr. El Kabany is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Liver Failure, and Visceromegaly.

Frequently Asked Questions about Dr. Alexander S. Kuo

How do I make an appointment with Dr. Alexander S. Kuo?

You can book an appointment with Dr. Alexander S. Kuo by calling their office at 310-423-2641. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alexander S. Kuo a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alexander S. Kuo is classified as an Distinguished expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alexander S. Kuo specialize in?

While Dr. Alexander S. Kuo is a Gastroenterology, they have specific expertise in Hepatitis, Hepatitis C, and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Alexander S. Kuo participate in research or clinical trials?

Yes. Dr. Alexander S. Kuo has published 76 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Alexander S. Kuo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alexander S. Kuo accept my insurance?

Dr. Alexander S. Kuo accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 310-423-2641 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kuo's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 20 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile